Cargando…
A flexural exanthem following postexposure prophylaxis
We report a case of symmetrical drug‐related intertriginous and flexural exanthema following antiretroviral postexposure prophylactic medications, tenofovir and emtricitabine, commencement of which preceded the onset of the rash. Tenofovir and emtricitabine are both nucleoside reverse transcriptase...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313790/ https://www.ncbi.nlm.nih.gov/pubmed/35297086 http://dx.doi.org/10.1111/ced.15131 |
_version_ | 1784754160044867584 |
---|---|
author | Roche, Darren Murray, Gregg Hackett, Catriona Tobin, Anne‐Marie |
author_facet | Roche, Darren Murray, Gregg Hackett, Catriona Tobin, Anne‐Marie |
author_sort | Roche, Darren |
collection | PubMed |
description | We report a case of symmetrical drug‐related intertriginous and flexural exanthema following antiretroviral postexposure prophylactic medications, tenofovir and emtricitabine, commencement of which preceded the onset of the rash. Tenofovir and emtricitabine are both nucleoside reverse transcriptase inhibitor medications, commonly used to prevent development of AIDS. [Image: see text] |
format | Online Article Text |
id | pubmed-9313790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93137902022-07-30 A flexural exanthem following postexposure prophylaxis Roche, Darren Murray, Gregg Hackett, Catriona Tobin, Anne‐Marie Clin Exp Dermatol Continuing Professional Development We report a case of symmetrical drug‐related intertriginous and flexural exanthema following antiretroviral postexposure prophylactic medications, tenofovir and emtricitabine, commencement of which preceded the onset of the rash. Tenofovir and emtricitabine are both nucleoside reverse transcriptase inhibitor medications, commonly used to prevent development of AIDS. [Image: see text] John Wiley and Sons Inc. 2022-03-17 2022-06 /pmc/articles/PMC9313790/ /pubmed/35297086 http://dx.doi.org/10.1111/ced.15131 Text en © 2022 The Authors. Clinical and Experimental Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Continuing Professional Development Roche, Darren Murray, Gregg Hackett, Catriona Tobin, Anne‐Marie A flexural exanthem following postexposure prophylaxis |
title | A flexural exanthem following postexposure prophylaxis |
title_full | A flexural exanthem following postexposure prophylaxis |
title_fullStr | A flexural exanthem following postexposure prophylaxis |
title_full_unstemmed | A flexural exanthem following postexposure prophylaxis |
title_short | A flexural exanthem following postexposure prophylaxis |
title_sort | flexural exanthem following postexposure prophylaxis |
topic | Continuing Professional Development |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313790/ https://www.ncbi.nlm.nih.gov/pubmed/35297086 http://dx.doi.org/10.1111/ced.15131 |
work_keys_str_mv | AT rochedarren aflexuralexanthemfollowingpostexposureprophylaxis AT murraygregg aflexuralexanthemfollowingpostexposureprophylaxis AT hackettcatriona aflexuralexanthemfollowingpostexposureprophylaxis AT tobinannemarie aflexuralexanthemfollowingpostexposureprophylaxis AT rochedarren flexuralexanthemfollowingpostexposureprophylaxis AT murraygregg flexuralexanthemfollowingpostexposureprophylaxis AT hackettcatriona flexuralexanthemfollowingpostexposureprophylaxis AT tobinannemarie flexuralexanthemfollowingpostexposureprophylaxis |